Microvasculature recovery by angiogenesis after myocardial infarction

Advances on early reperfusion therapies focused on the revascularization of the ischemic tissues have lead, in the last decades, to reduced mortality in acute myocardial infarction (MI) patients. However, a large proportion of patients show inadequate myocardial perfusion because of dysfunction of t...

Full description

Saved in:
Bibliographic Details
Published inCurrent pharmaceutical design
Main Authors Badimon, Lina, Borrell, Maria
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2018
Subjects
microvascular dysfunction
reperfusion therapies
angiogenesis
myocardial infarction
Online AccessGet more information

Cover

More Information
Summary:Advances on early reperfusion therapies focused on the revascularization of the ischemic tissues have lead, in the last decades, to reduced mortality in acute myocardial infarction (MI) patients. However, a large proportion of patients show inadequate myocardial perfusion because of dysfunction of the microcirculation. The high prevalence of microvascular dysfunction after reperfusion therapies and the negative prognostic of this procedure justify the search for therapeutic strategies that aim to restore the microvascular network. It is well known that the size of the initial infarct, the duration of ischemia and the efficiency of reperfusion determine myocardial tissue damage and cardiomyocyte loss after myocardial infarction. Therefore any advancement on the mechanisms that induce the repair process of microvascular dysfunction after reperfused MI is of great interest. Here we will review the different proteins and cells known to participate in angiogenesis induction post MI and we will also discuss the potential pharmacological and cellular processes that promote the recovery of microvasculature by angiogenesis stimulation after MI.
ISSN:1873-4286
DOI:10.2174/1381612824666180629162726